EA202192197A1 - IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS TLR7 AGONISTS - Google Patents

IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS TLR7 AGONISTS

Info

Publication number
EA202192197A1
EA202192197A1 EA202192197A EA202192197A EA202192197A1 EA 202192197 A1 EA202192197 A1 EA 202192197A1 EA 202192197 A EA202192197 A EA 202192197A EA 202192197 A EA202192197 A EA 202192197A EA 202192197 A1 EA202192197 A1 EA 202192197A1
Authority
EA
Eurasian Patent Office
Prior art keywords
imidazo
triazine
amine derivatives
tlr7 agonists
triazin
Prior art date
Application number
EA202192197A
Other languages
Russian (ru)
Inventor
Голян Чжан
Цзяньчжуан Мяо
Чаню Чжоу
Ган Чэнь
Цзин Ли
Original Assignee
Бейджин, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бейджин, Лтд. filed Critical Бейджин, Лтд.
Priority claimed from PCT/CN2020/074437 external-priority patent/WO2020160711A1/en
Publication of EA202192197A1 publication Critical patent/EA202192197A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В данном документе раскрыто производное имидазо[2,1-f][1,2,4]триазин-4-амина, или его стереоизомер, или его фармацевтически приемлемая соль, применимое в качестве агониста TLR7, и содержащая его фармацевтическая композиция. Также в данном документе раскрыт способ лечения рака с применением производного имидазо[2,1-f][1,2,4]триазин-4-амина, или его стереоизомера, или его фармацевтически приемлемой соли в качестве агониста TLR7.This document discloses an imidazo [2,1-f] [1,2,4] triazin-4-amine derivative or a stereoisomer or a pharmaceutically acceptable salt thereof useful as a TLR7 agonist and a pharmaceutical composition thereof. Also disclosed herein is a method for treating cancer using an imidazo [2,1-f] [1,2,4] triazin-4-amine derivative or a stereoisomer or a pharmaceutically acceptable salt thereof as a TLR7 agonist.

EA202192197A 2020-01-22 2020-02-06 IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS TLR7 AGONISTS EA202192197A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2020073673 2020-01-22
PCT/CN2020/074437 WO2020160711A1 (en) 2019-02-07 2020-02-06 Imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivatives as tlr7 agonist

Publications (1)

Publication Number Publication Date
EA202192197A1 true EA202192197A1 (en) 2021-11-24

Family

ID=78768146

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202192195A EA202192195A1 (en) 2020-01-22 2020-02-06 IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS A TLR7 AGONIST
EA202192197A EA202192197A1 (en) 2020-01-22 2020-02-06 IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS TLR7 AGONISTS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA202192195A EA202192195A1 (en) 2020-01-22 2020-02-06 IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS A TLR7 AGONIST

Country Status (1)

Country Link
EA (2) EA202192195A1 (en)

Also Published As

Publication number Publication date
EA202192195A1 (en) 2021-11-16

Similar Documents

Publication Publication Date Title
MX2021009444A (en) Imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivatives as tlr7 agonist.
MX2022007350A (en) Pyrazolyl derivatives useful as anti-cancer agents.
MX2022008066A (en) Substituted tricyclic compounds.
PH12021550442A1 (en) Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof
EA202092036A1 (en) PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES AS ANTAGONIST OF THE A2A RECEPTOR
MX2021012423A (en) Methods and compositions for targeted protein degradation.
EA201691142A1 (en) MEK INHIBITORS AND METHODS OF THEIR APPLICATION
EA200501849A1 (en) DERIVATIVES OF PYRAZOLOHINAZOLINE: METHOD FOR OBTAINING AND USING AS KINAZ INHIBITORS
EA200600209A1 (en) PYRROLO [3,4-c] DERIVATIVES OF PYRAZOLE, ACTIVATED AS KINASE INHIBITORS
CO5271709A1 (en) COMPOSITIONS AND PROCEDURES FOR THE AND TREATMENT OF AFFECTIONS RESPONDING TO STROGENS
EA200400737A1 (en) PREPARATION OF AMINO ACIDS AND RIBOFLAVIN APPLICABLE TO REDUCE THE TOXIC EFFECT OF CYTOTOXIC CHEMOTHERAPY
MX2022010512A (en) Bcl-2 protein inhibitors.
MX2021007247A (en) Rapamycin derivatives.
MX2022000310A (en) Bcl-2 protein inhibitors.
MX2019006612A (en) IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS.
MX2020002630A (en) IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS.
MX2023000943A (en) Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same.
MX2021015724A (en) Pharmaceutical composition for treating acute myeloid leukemia, containing flt3 inhibitor and chemotherapeutic agents.
MX2020011453A (en) Combinations for treating cancer.
ZA202308282B (en) Toxin molecule suitable for antibody-drug conjugate
WO2024044667A3 (en) Small molecule inhibitors of kras proteins
MX2024001560A (en) Methods of treating migraine with mnk inhibitors.
MX2021010115A (en) Pharmaceutical composition comprising flt3 inhibitor and hypomethylating agent for treating acute myeloid leukemia.
EA202192197A1 (en) IMIDAZO [2,1-f] [1,2,4] TRIAZINE-4-AMINE DERIVATIVES AS TLR7 AGONISTS
EA200400695A1 (en) SUBSTITUTED BENZOPIRANE AS A SELECTIVE AGENT OF BETA RECEPTOR ESTROGEN